Maven Clinic is poised for an IPO, having just secured a $125 million Series F round, bringing its valuation to $1.7 billion. This financial growth, alongside its leadership shift, suggests a strategic pivot towards greater expertise in navigating public markets as it prepares for potential public offering.
The departure of Kristina Campbell, who was with Maven CFO for just a year, underscores the rapid changes within the company. The decision to seek a new CFO with public market experience indicates Maven's serious intent to evolve from startup to public company, reflecting the dynamic landscape of women’s health startups.
Collection
[
|
...
]